At this year’s ISPOR, Precision Xtract’s Larry Blandford and Precision Health Economics’ Jason Shafrin met with BioPharm Insights to illuminate the importance of shifting to value-based assessment and examine reasons why US payers are slow to adopt the model. (more…)
Precision for Value’s Andrew Cournoyer is featured in Specialty Pharmacy News discussing the FDA’s discretion over the Biologics Price Competition and Innovation Act of 2009 (BPCIA) and the impact the deemed drafted guidance has over biosimilar adoption. (more…)
As new cellular and genetic therapies are attracting interest in regenerative medicine, payers are struggling to stave off large upfront costs. (more…)
As rapidly as cancer treatments are advancing, so is pricing. To help find ways to reduce drug costs, payers must focus on exploring types of value-based payments. (more…)
Following their presentation at AMCP 2018, Maureen and Elizabeth talked with Managed Healthcare Executive to discuss the importance of Motivational Interviewing and shared some of their tips for successfully conducting motivational interviews. (more…)
Dominic Galante explains how a fragmented Health Technology Assessment landscape in the United States is one of many struggles medical devices face when determining healthcare value.
Addition of London-based multichannel healthcare agency complements and strategically expands existing global expertise and capabilities
BOSTON, MA – April 24, 2018 – precisioneffect, the healthcare advertising agency dedicated to working with companies that seek to change the standard of care, today announced it is acquiring Big Pink, a leading European multichannel marketing healthcare agency recognized for providing strategically designed and creatively delivered campaigns to the pharmaceutical industry worldwide. The acquisition marks an important expansion of precisioneffect’s global footprint and employee base, and positions the company to provide its clients with additional value through enhanced services and expertise. (more…)
TAPPING FORMER PAYER DECISION MAKERS BOYCE, HONCZ AND OYEKAN
BRINGS UNRIVALED INSIGHTS TO CLIENTS
APRIL 18th, 2018 – New York, NY – Precision for Value, the market leader in supporting global pharmaceutical and life sciences companies in demonstrating the value and outcomes of innovative medical products, today announced significant additions to its Payer Strategy Team with the hiring of former payer executives Marylou Buyse, Joe Honcz, and Elizabeth Oyekan. (more…)
In an article in Pharmaceutical Commerce, Precision’s Dominic Galante and Maureen Hennessey stress the importance of patient support services among pharma companies, payers, and providers. (more…)
In a sit-down Q&A with PM360, Jeremy Schafer provides clarity and insight on the potential impact UnitedHealthcare’s new rebate plan will have on pharma. (more…)